SeraCare Life Sciences, Inc. (SRLS) Tops Q1 EPS by 3c, Sales Top Expectations

SeraCare Life Sciences, Inc. (NASDAQ: SRLS) reported Q1 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.05 million.

For earnings history and earnings-related data on SeraCare Life Sciences, Inc. (SRLS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• BMO starts chip stocks coverage: Here are its preferred picks